Skip to main content

Table 4 Correlations between HRQoL and HU measures: EU and Non-EU cohorts

From: Use of health-related quality of life measures to predict health utility in postmenopausal osteoporotic women: results from the Multiple Outcomes of Raloxifene Evaluation study

Non-EU cohort

EU cohort

OPAQ vs. HUI

NHP vs. HUI

QualEFFO vs. EQ-5D

NHP vs. EQ-5D

OPAQ domain

r

NHP Domain

r

QualEFFO domain

r

NHP domain

r

Walking/Bending

0.524

Emotional reaction

−0.393

Pain

0.571

Emotional reaction

−0.561

Standing/Sitting

0.490

Energy

−0.477

Daily activity

0.713

Energy

−0.593

Dressing/Reaching

0.325

Physical mobility

−0.506

Mobility

0.657

Physical mobility

−0.596

Household/Self care

0.335

Pain

−0.578

General health

0.558

Pain

−0.650

Transfers

0.416

Sleep

−0.386

Mental health

0.540

Sleep

−0.335

Usual work

0.400

Social interaction

−0.272

Overall QOL

0.515

Social interaction

−0.347

Fear of falls

0.456

      

Level of tension

0.342

      

Body image

0.265

      

Independence

0.405

      

Back pain

0.495

      

Fatigue

0.444

      

Social activity

0.116*

      

Support, family and friends

0.093*

      
  1. Abbreviations: EU European Union, HUI Health Utility Index, NHP Nottingham Health Profile, Non-EU Non-European Union, OPAQ Osteoporosis Assessment Questionnaire, QOL quality of life, QualEFFO EU Foundation of Osteoporosis Quality-of-Life Assessment, r = Pearson’s correlation coefficient estimate.
  2. Scoring: OPAQ scores: 0 (worst) - 100 (best), HUI scores: 0 (worst) - 1.0 (best), NHP scores: 0 (best) - 100 (worst), EQ-5D scores: 0 (worst) - 1.0 (best). QualEFFO scores (54-item QualEFFO): 0 (worst) - 100 (best).
  3. *p < 0.05, p < 0.0001 for all other coefficients.
Back to article page

Health and Quality of Life Outcomes

ISSN: 1477-7525

Contact us